Global Health Diagnostics | June 2-3, 2022
Online only. Course will be live approximately 8:00am-12:00pm (Montreal time) each day June 2-3, 2022. Live content will be recorded.
This 2 day online seminar on global health diagnostics will focus on cross-cutting issues affecting the Infectious Diseases Diagnostics space, including sexually transmitted and blood borne infections (STBBIs), acute febrile illnesses, selected neglected tropical diseases (NTDs), in addition to HIV, TB, Malaria and COVID-19.
Attendees can expect a mix of plenary talks, engaging panel discussions and tech pitches from industry leaders.
Participants will learn from an array of stakeholders including product manufacturers, donors, product development partnerships, policy makers, academics, clinicians, researchers, community advocates, program managers, public health implementers and health leaders from in high burden countries.
Cédric Yansouni, MD, FRCPC, DTM&H
Assistant Professor, Divisions of Infectious Diseases and Medical Microbiology, McGill University Health Centre;
Associate Director, J.D. MacLean Centre for Tropical Diseases
Nitika Pant Pai, MD, MPH, PhD
Associate Professor, Division of Clinical Epidemiology & Infectious Diseases, McGill University;
Center for Outcomes Research and Evaluation, MUHC Research Institute
PREVIOUS COURSE FACULTY
- Tanya Applegate, PhD – Kirby Institute, Australia
- Lee Schroeder, MD PhD- University of Michigan
- Emmanuel Bottieau, MD – Institute of Tropical Medicine, Antwerp, Belgium
- Peter Dailey, PhD, MPH – UC Berkeley, USA
- Rashidul Haque – International Centre for Diarrhoeal Disease Research, Bangladesh
- Ilesh Jani, MD, PhD – Instituto Nacional de Saude, Mozambique
- Trevor Peter, PhD – Clinton Health Access Initiative, Washington DC. USA
- Prashant Yadav, PhD, MBA – Bill & Melinda Gates Foundation
- Semaria Solomon – St. Paul’s Millennium Medical College
- Wondewosen Tsegaye Sime – St. Paul’s Millennium Medical College
- Adisu Kebede – Ethiopian Public Health Institute
- David Goldfarb, MD – University of British Columbia
- Mark Miller – Biomerieux
- Jeffery Pernica- McMaster University
Faculty are still being confirmed and there may be changes to the above list.
Infectious diseases continue to pose a major threat to the health of most developing nations. The COVID-19 pandemic and emergence and spread of infections like XDR-TB, Ebola, dengue, chikungunya, and avian influenza have highlighted the importance of effective global response to epidemic threats.
Diagnosis is a critical step in effective disease care and control, but many people in developing countries do not have access to high quality diagnostic tests.
In this popular course, professionals ranging from clinicians, nurses, policy-makers, researchers, implementers, advocates and health educators gather to share their rich and diverse experiences, successes, failures and lessons learned in launching, leading, important diagnostic initiatives, globally. They ask important questions that help advance the field of global health diagnostics.
- Convene key stakeholder groups on global health diagnostics to create a platform for information exchange and knowledge transfer.
- Inform, educate, engage and convene discussions on pertinent issues in diagnostics so as to inform the direction of future practice, policy and funding initiatives for diagnostics.
- Dissect the value chain for global health diagnostics development, current pipeline of diagnostics, market size and dynamics, policies on diagnostics, and barriers for scale-up for selected infectious diseases of global health importance across all infections.
- Debate and propose solutions for accelerating market entry for innovative diagnostics, to sustain and support manufacturers’ engagement in development of new diagnostics that address unmet global health needs.
- Debate and identify novel approaches to scale-up, including innovative business models that leverage market-based incentives.
This course appeals to a wide range of participants including:
- Policy makers and ministry officials
- Researchers, academics, and students/fellows studying global health or infectious disease
- Product developers, and industry
- Funders and public health agency officials
- Community advocacy groups working in diagnostics and global health